Head-to-head · Cost-Efficiency Index
LaSara Medical Group vs eMed
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
LaSara Medical Group
Shoppers who want a hybrid in-person/telehealth GLP-1 option in Southern California and are comfortable prepaying a year for the lowest rate.
Visit LaSara Medical GroupeMed
Cost-first shoppers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
Visit eMedThe verdict
LaSara Medical Group takes it, leading the Cost-Efficiency Index 45 to 44. LaSara Medical Group is a hybrid national-telehealth-plus-Southern-California-in-person provider selling compounded semaglutide (from $299/mo month-to-month, down to $233/mo equivalent on a $2,795 12-month prepay) and tirzepatide (from $399/mo, down to $325/mo equivalent on a $3,895 12-month prepay). eMed still earns a C — Cost-first shoppers who want employees whose company offers eMed GLP-1 benefits and wants at-home labs.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs LaSara Medical Group.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | LaSara Medical Group | eMed |
|---|---|---|
| Cost-Efficiency Index | 45/100 | 44/100 |
| Semaglutide / mo | $299/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide / mo | $399/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $3,588 | — |
| Tirzepatide / yr (modeled) | $4,788 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #465 | #472 |
LaSara Medical Group
45/100Where the value is
- Full, clean 4-tier pricing tables published for both drugs with exact dollar totals at every commitment length — real transparency, no gating behind intake
- Named clinical leadership: Medical Director Dr. Sunil Kurup and Founder/CEO John Snedegar
- Rare hybrid model — national telehealth plus an actual in-person Southern California option, alongside a broader hormone/peptide menu (TRT, NAD+, sermorelin, B12, enclomiphene)
The tradeoffs
- The lowest advertised per-month figures ($233 sema / $325 tirz) require a full 12-month prepay charged upfront ($2,795 / $3,895 at once) — the real month-to-month price is $299 / $399, 28-33% higher
- States served are not disclosed anywhere on the pricing pages despite the 'national telehealth' claim
eMed
44/100Where the value is
- Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
- At-home blood collection makes lab work convenient
- Clinician review and ongoing side-effect plus adherence support
The tradeoffs
- Distributed mainly via employers, with limited direct cash-pay access
- No public transparent monthly price for individuals
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.